5th International Conference on Heart and Cardiovascular Diseases

Interventional cardiology continues to redefine what is achievable without open surgery. TAVI now accounts for the majority of aortic valve replacements across all surgical risk categories, and transcatheter therapies are rapidly expanding to mitral and tricuspid valve disease. The Interventional Cardiology session examines 5-year TAVI outcomes in low-risk patients, the COAPT-established evidence base for transcatheter mitral edge-to-edge repair (TEER), emerging transcatheter tricuspid therapies, left atrial appendage occlusion, and physiology-guided PCI using iFR/FFR with intravascular imaging - including chronic total occlusion PCI and complex left main disease management.

Key Discussion Areas:

• Advances in complex percutaneous coronary intervention (PCI)
• Transcatheter approaches to structural heart disease
• Intracoronary imaging and physiology-guided intervention
• Techniques for chronic total occlusion (CTO) recanalization
• Emerging device technology and procedural innovation
• Procedural safety, complications, and outcomes data

Sub Tracks

• Percutaneous Coronary Intervention (PCI)
• Transcatheter Structural Heart Procedures
• Chronic Total Occlusion (CTO) Techniques
• Intravascular Imaging & Physiology-Guided PCI
• Peripheral & Endovascular Interventions
• Device & Technology Innovation

Why Attend This Session?

Interventional cardiologists, cardiac surgeons, structural heart disease teams, and cath lab professionals will gain comprehensive updates on trial evidence, device selection algorithms, and operator technique across coronary and structural heart interventions, bridging innovation with real-world implementation.

Related Topics

Coronary & Ischemic Heart Disease | Cardiovascular Surgery | Cardiovascular Imaging | Vascular & Aortic Diseases

Frequently Asked Questions

Q: What is covered under Interventional Cardiology?

A: Catheter-based treatments for coronary and structural heart disease, including PCI, structural interventions, and CTO techniques.

Q: Who typically attends this track?

A: Interventional cardiologists, cath lab staff, and device researchers.

Q: Does this track include structural heart procedures?

A: Yes, transcatheter structural heart interventions are a core sub-track.

Q: Is imaging-guided intervention discussed?

A: Yes, intravascular imaging and physiology-guided PCI are dedicated discussion areas.

Q: How does this track relate to Cardiovascular Surgery?

A: The two tracks often intersect on structural and revascularization cases where transcatheter and surgical approaches are compared.